In this study, we demonstrated that IL-36γ activates the MEK/ERK and JNK/c-Jun signaling pathways via IL-36R, resulting in the activation of c-Fos, c-Jun, and AP-1 transcription factors in breast cancer cells. The gene discussed is IL36G; the disease is breast carcinoma.